Diversified Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $671K | Buy |
+9,962
| New | +$664K | 0.01% | 658 |
|
|
2026
Q1 | – | Sell |
-11,524
| Closed | -$765K | – | 1076 |
|
|
2025
Q4 | $765K | Buy |
11,524
+1,726
| +18% | +$112K | 0.01% | 525 |
|
|
2025
Q3 | $659K | Sell |
9,798
-8,051
| -45% | -$637K | 0.01% | 540 |
|
|
2025
Q2 | $1.56M | Sell |
17,849
-1,586
| -8% | -$124K | 0.03% | 286 |
|
|
2025
Q1 | $1.33M | Buy |
19,435
+2,078
| +12% | +$170K | 0.03% | 291 |
|
|
2024
Q4 | $1.35M | Sell |
17,357
-20,175
| -54% | -$1.49M | 0.03% | 302 |
|
|
2024
Q3 | $2.52M | Sell |
37,532
-22,749
| -38% | -$1.87M | 0.06% | 191 |
|
|
2024
Q2 | $6.83M | Buy |
60,281
+1,057
| +2% | +$134K | 0.19% | 61 |
|
|
2024
Q1 | $8.21M | Buy |
59,224
+90
| +0.2% | +$11.3K | 0.25% | 54 |
|
|
2023
Q4 | $7.34M | Buy |
59,134
+1,850
| +3% | +$189K | 0.25% | 54 |
|
|
2023
Q3 | $5.34M | Sell |
57,284
-1,879
| -3% | -$212K | 0.2% | 64 |
|
|
2023
Q2 | $7.6M | Buy |
59,163
+1,283
| +2% | +$155K | 0.28% | 48 |
|
|
2023
Q1 | $6.72M | Buy |
57,880
+1,792
| +3% | +$201K | 0.26% | 50 |
|
|
2022
Q4 | $6.35M | Sell |
56,088
-2,162
| -4% | -$237K | 0.26% | 49 |
|
|
2022
Q3 | $4.69M | Sell |
58,250
-2,449
| -4% | -$207K | 0.21% | 62 |
|
|
2022
Q2 | $4.52M | Buy |
60,699
+25,511
| +72% | +$2.33M | 0.19% | 63 |
|
|
2022
Q1 | $4.5M | Buy |
35,188
+33,548
| +2,046% | +$3.67M | 0.16% | 80 |
|
|
2021
Q4 | $220K | Sell |
1,640
-52
| -3% | -$7.47K | 0.01% | 741 |
|
|
2021
Q3 | $231K | Buy |
+1,692
| New | +$213K | 0.01% | 671 |
|
|
2021
Q1 | – | Sell |
-3,552
| Closed | -$328K | – | 797 |
|
|
2020
Q4 | $328K | Hold |
3,552
| – | – | 0.01% | 478 |
|
|
2020
Q3 | $366K | Buy |
3,552
+608
| +21% | +$63.5K | 0.02% | 382 |
|
|
2020
Q2 | $298K | Buy |
+2,944
| New | +$263K | 0.02% | 398 |
|
|
2016
Q3 | – | Sell |
-53,952
| Closed | -$1.07M | – | 309 |
|
|
2016
Q2 | $1.07M | Buy |
+53,952
| New | +$919K | 0.12% | 156 |
|
|
2015
Q2 | – | Sell |
-14,204
| Closed | -$221K | – | 474 |
|
|
2015
Q1 | $221K | Sell |
14,204
-30,472
| -68% | -$460K | 0.02% | 465 |
|
|
2014
Q4 | $615K | Buy |
+44,676
| New | +$547K | 0.06% | 294 |
|
|
2014
Q2 | $1.48M | Buy |
+148,956
| New | +$1.32M | 0.12% | 197 |
|
|
2013
Q4 | $2.3M | Sell |
260,100
-59,560
| -19% | -$471K | 0.23% | 62 |
|
|
2013
Q3 | $2.25M | Sell |
319,660
-12,440
| -4% | -$78.8K | 0.24% | 72 |
|
|
2013
Q2 | $1.86M | Buy |
+332,100
| New | +$1.59M | 0.22% | 68 |
|
Other funds holding DXCM
FFM
PCM
OIAM
GI
BIAS
EOJOAM
CNB
Diversified Trust's DXCM Position: Q2 2026 in Review
Diversified Trust opened a new position in DexCom (DXCM) in Q2 2026: 9,962 shares worth $671K. The stake represents 0.01% of the portfolio and ranks #658 among its holdings. This is a return to the name: Diversified Trust previously reported a position in DXCM as recently as Q4 2025.
Diversified Trust first reported a position in DXCM in Q2 2013 and has held it in 29 quarters since. The position peaked at $8.21M in Q1 2024. 115 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Diversified Trust held 9,962 shares of DexCom worth $671K as of Q2 2026.
- DexCom was a new Diversified Trust position in Q2 2026.
- DexCom made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #658 holding.
- Diversified Trust first reported a position in DexCom in Q2 2013 and has held it in 29 quarters since.
- Diversified Trust's DexCom position peaked at $8.21M in Q1 2024.
- 115 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.